Prospective open- label trial with rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy not responding to conventional immune therapies.

Subjects

Subjects :

CHRONIC inflammatory demyelinating polyradiculoneuropathy
HEMATOPOIETIC stem cell transplantation
B cell differentiation
NERVE conduction studies
MEDICAL sciences
POLYNEUROPATHIES
HEART failure

Details

Language :

English

ISSN :

00223050

Volume :

95

Issue :

9

Database :

Complementary Index

Journal :

Journal of Neurology, Neurosurgery & Psychiatry

Publication Type :

Academic Journal

Accession number :

179768589

Full Text :

https://doi.org/10.1136/jnnp-2023-332844